Breast Neoplasms Clinical Trial
Official title:
A Randomized Controlled Trial of a Group Intervention for Women With a Family History of Breast Cancer
One in 10 Canadian women will be diagnosed with breast cancer (BC) and approximately 5% of all BC is believed to be hereditary. Women with a family history experience high levels of perceived risk for developing BC. Elevated risk perceptions for BC have been associated with psychological distress, which, in turn, can interfere with screening adherence. In our completed CBCRI-funded study, we developed and standardized a group intervention designed to address the psychological issues associated with having a family history of BC. Results demonstrated that the intervention led to significant improvement in levels of anxiety and depression, improved BC risk factors/genetics knowledge and was associated with optimal screening behavior. The proposed study will rigorously test the group intervention in comparison to standard risk counselling in a sample of 150 women recruited from Familial BC clinics in Toronto. The interventions will be examined for their impact on a) psychological functioning, b) BC risk/genetic knowledge and c) screening behaviors.
Keywords: Breast cancer, genetics, psychotherapy, group counselling, randomized control
trial, risk counselling, women's mental health, familial breast cancer.
One in 10 Canadian women will be diagnosed with breast cancer (BC) and approximately 5% of
all BC is believed to be hereditary. Women with a family history of BC experience high
levels of perceived risk and vulnerability for developing BC. Elevated risk perceptions for
BC are difficult to modify and have been associated with psychological distress that, in
turn, can interfere with screening adherence. The specific objectives of the current
randomized trial are to determine the effects of a supportive-expressive group intervention
on a) psychosocial functioning (using standardized instruments), b) BC risk/genetic
knowledge and c) screening behaviors in women with a family history of breast cancer
receiving standard genetic risk counseling. Preliminary data will be collected to examine
the cost effectiveness of the intervention.
The study is being conducted in the following University of Toronto affiliated teaching
hospitals: Mount Sinai Hospital; Preventive Oncology Program, Sunnybrook and Women's College
Health Sciences; Toronto Sunnybrook Regional Cancer Centre; University Health Network; North
York General Hospital; Credit Valley Hospital. A total of 150 women with a family history of
BC will be randomized in a ratio of 2 to 1 to participate in an 8 weekly/ 4 monthly support
group or to a control arm that receives educational materials.
The study has been funded by the Canadian Breast Cancer Research Initiative (CBCRI) of the
National Cancer Institute of Canada since 2001. To date 66 women have been enrolled in the
study and we anticipate a total of 90 women will be enrolled by the end of the current
funding year in June 2004. At this rate it is expected that recruitment will be completed in
June 2005, the last intervention groups will be completed by January 2006 and that analysis
of the final study results will be completed by June 2006. Analysis of baseline data will
begin in September 2005 once the last study groups have been initiated and a manuscript
reporting the final results will be prepared by June 2006. Two years of funding is requested
for these activities.
Significance: Technological advances in molecular biology and genetics are occurring
rapidly. Our proposed research has direct relevance for advancing knowledge on the
communication and provision of risk/genetic information to individuals with a family history
of BC and has both direct and indirect relevance to individuals at all stages of cancer.
Improved counselling techniques for those with a family history may impact on the prevention
and management of BC through improved surveillance and preventive techniques, enhanced
psychosocial functioning and wellbeing through increased psychological resilience. In
addition, effective risk counselling interventions may facilitate the understanding of and
decision-making around genetic testing, and the adjustment to a cancer diagnosis, should
these women with family histories later develop the disease.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Enrolling by invitation |
NCT05558917 -
Comparison Between PECS BLOCK 2 vs ESP BLOCK in Ocnologic Breast Surgery
|
N/A | |
| Active, not recruiting |
NCT03664778 -
Abbreviated Breast MRI After Cancer Treatment
|
||
| Recruiting |
NCT03144622 -
18F-FSPG PET/CT Imaging in Patients With Cancers
|
||
| Completed |
NCT05452499 -
Pain Neuroscience Education and Therapeutic Exercise as a Treatment for Breast Cancer Survivors Living With Sequelae
|
N/A | |
| Active, not recruiting |
NCT04568902 -
Study of H3B-6545 in Japanese Women With Estrogen Receptor (ER)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer
|
Phase 1 | |
| Completed |
NCT02860585 -
Evaluation of Survival in Patients With Metastatic Breast Cancer Receiving High-dose Chemotherapy With Autologous Haematopoietic Stem Cell Transplantation
|
N/A | |
| Completed |
NCT04059809 -
Photobiomodulation for Breast Cancer Radiodermatitis
|
Phase 2/Phase 3 | |
| Recruiting |
NCT04557449 -
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
|
Phase 1/Phase 2 | |
| Completed |
NCT03698942 -
Delphinus SoftVueâ„¢ ROC Reader Study
|
||
| Completed |
NCT00092950 -
Exercise in Women at Risk for Breast Cancer
|
Phase 2 | |
| Terminated |
NCT04123704 -
Sitravatinib in Metastatic Breast Cancer
|
Phase 2 | |
| Not yet recruiting |
NCT02151071 -
The Breast Surgery EnLight and LightPath Imaging System Study
|
Phase 1/Phase 2 | |
| Recruiting |
NCT02934360 -
TR(ACE) Assay Clinical Specimen Study
|
N/A | |
| Active, not recruiting |
NCT02950064 -
A Study to Determine the Safety of BTP-114 for Treatment in Patients With Advanced Solid Tumors With BRCA Mutations
|
Phase 1 | |
| Completed |
NCT02931552 -
Nuevo Amanecer II: Translating a Stress Management Program for Latinas
|
N/A | |
| Not yet recruiting |
NCT02876848 -
A Novel E-Health Approach in Optimizing Treatment for Seniors (OPTIMUM Study)
|
N/A | |
| Recruiting |
NCT02547545 -
Breast Cancer Chemotherapy Risk Prediction Mathematical Model
|
N/A | |
| Completed |
NCT02303366 -
Pilot Study of Stereotactic Ablation for Oligometastatic Breast Neoplasia in Combination With the Anti-PD-1 Antibody MK-3475
|
Phase 1 | |
| Completed |
NCT02652975 -
Anticancer Treatment of Breast Cancer Related to Cardiotoxicity and Dysfunctional Endothelium
|
N/A | |
| Completed |
NCT02518477 -
Preventive Intervention Against Lymphedema After Breast Cancer Surgery
|
N/A |